Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126432892 | 12643289 | 2 | F | 201406 | 20160816 | 20160811 | 20160819 | PER | PHEH2016US019513 | NOVARTIS | 57.01 | YR | F | Y | 81.00000 | KG | 20160819 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126432892 | 12643289 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 400 MG, BID | 21588 | 400 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126432892 | 12643289 | 1 | Gastrointestinal stromal tumour |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126432892 | 12643289 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126432892 | 12643289 | Atelectasis | |
126432892 | 12643289 | Diverticulitis | |
126432892 | 12643289 | Gastrointestinal stromal tumour | |
126432892 | 12643289 | Lip dry | |
126432892 | 12643289 | Metastases to liver | |
126432892 | 12643289 | Rash | |
126432892 | 12643289 | Recurrent cancer | |
126432892 | 12643289 | Uterine leiomyoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126432892 | 12643289 | 1 | 2014 | 201506 | 0 |